Prion function and dysfunction: A structure-based scenario

Medical Hypotheses

Volumn 46, Issue 3, 1996, Pages 225-228

  Radulescu, R T ^a   Korth, C ^b  

^a Molecular Concepts Research MCR   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RIBONUCLEOPROTEIN; RIBOZYME;

HUMAN; HYPOTHESIS; MODEL; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SHORT SURVEY;

MAMMALIA;

EID: 0029988358     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90245-5     Document Type: Article

References (33)

1. Wickner RB. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994; 264: 566-569.
2. Tuite MF. Psi no more for yeast prions. Nature 1994; 370: 327-328.
3. Tuite M F, Stansfield I. Knowing when to stop. Nature 1994; 372: 614-615.
4. Cohen F E, Pan K-M, Huang Z, Baldwin M, Fletterick R J, Prusiner S B. Structural clues to prion replication. Science 1994; 264: 530-531.
5. Riesner D, Kellings K, Wiese U, Wulfert M, Mirenda C, Prusiner S B. Prions and nucleic acids: search for residual nucleic acids and screening for mutations in the PrP-gene. Dev Biol Stand 1993; 80: 173-181.
6. Oesch B, Westaway D, Wälchli M et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40: 735-746.
7. Kretzschmar HA, Stowring L A, Westaway D, Stubblebine W H, Prusiner S B, DeArmond S J. Molecular cloning of a human prion protein cDNA. DNA 1986; 5: 315-324.
8. Casas-Finet J R, Smith Jr J D, Kumar A, Kim J G, Wilson S H, Karpel RL. Mammalian heterogeneous ribonucleoprotein Al and its constituent domains - nucleic acid interaction, structural stability and self-association. J Mol Biol 1993; 229: 873-889.
9. Iwasaki M, Okumura K, Kondo Y, Tanaka T, Igarashi H. cDNA cloning of a novel heterogeneous nuclear ribonucleoprotein gene homologue in Caenorhabditis elegans using hamster prion protein cDNA as a hybridization probe. Nucleic Acids Res 1992; 20: 4001-4007.
10. Pfeifer K, Bachmann M, Schroder H C, Forrest J, Muller W E. Kinetics of expression of prion protein in uninfected and scrapie-infected N2a mouse neuroblastoma cells. Cell Biochem Funct 1993; 11: 1-11.
11. Beyreuther K. CIBA Found Symp 1988; 135: 179.
12. Weissmann C. A 'unified theory' of prion propagation. Nature 1991; 352: 679-683.
13. Hecker R, Taraboulos A, Scott M et al. Replication of distinct prion prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev 1992; 6: 1213-1228.
14. Pan K-M, Baldwin M, Nguyen J et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993; 90: 10962-10966.
15. Huang Z, Gabriel J-M, Baldwin M A, Fletterick R J, Prusiner S B, Cohen F E. Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci USA 1994; 91: 7139-7143.
16. Lambowitz A M, Perlman P S. Involvement of aminoacyl-tRNA synthetases and other proteins in group I and group II intron splicing. Trends Biochem Sci 1990; 15: 440-444.
17. Biebricher C K, Eigen M, Luce R. Template-free RNA synthesis by Qβ replicase. Nature 1986; 321: 89-91.
18. Manuelidis L, Sklaviadis T, Manuelidis E E. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J 1987; 6: 341-347.
19. Xi Y G, Ingrosso L, Ladogana A, Masullo C, Pocchiari M. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 1992; 356: 598-601.
20. Sakaguchi S, Katamine S, Yamanouchi K et al. Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice. J Gen Virol 1993; 74: 2117-2123.
21. Owen F, Poulter M, Lofthouse R et al. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1989; i: 51-52.
22. Goldfarb L G, Brown P, McCombie W R et al. Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PNRP gene. Proc Natl Acad Sci USA 1991; 88: 10926-10930.
23. Palmer M S, Mahal S P, Campbell T A et al. Deletions in the prion protein gene are not associated with CJD. Nucleic Acids Res 1993; 2: 541-554.
24. Hentze M W. Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains? Trends Biochem Sci 1994; 19: 101-103.
25. Oesch B. Characterization of PrP binding proteins. Phil Trans R Soc Lond B 1994; 343: 443-445.
26. Milner J, Medcalf E A. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 1991; 65: 765-774.
27. Oberosler P, Hloch P, Ramsberger U, Stahl H. p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J 1993; 12: 2389-2396.
28. Marechal V, Elenbaas B, Piette J, Nicolas J-C, Levine A J. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexs. Mol Cell Biol 1994; 14: 7414-7420.
29. Hainaut P, Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 1993; 53: 4469-4473.
30. Narang H K. Evidence that homologous ssDNA is present in scrapie, Creutzfeldt-Jakob disease, and bovine spongiform encephalopathy. Ann N Y Acad Sci 1994; 724: 314-326.
31. Burd C G, Dreyfuss G. RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J 1994; 13: 1197-1204.
32. Barbieri M, Maraldi N M. The riboskeleton: the 'brain' of the cell? Riv Biol/B Forum 1993; 86: 361-375.
33. Scrutton NS, Berry A, Perham, R N. Redesign of the coenzyme specificity of a dehydrogenase by protein engineering. Nature 1990; 343: 38-43.